132 related articles for article (PubMed ID: 7480156)
1. Potentiation of merocyanine 540-mediated photodynamic therapy by salicylate and related drugs.
Traul DL; Anderson GS; Bilitz JM; Krieg M; Sieber F
Photochem Photobiol; 1995 Oct; 62(4):790-9. PubMed ID: 7480156
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of merocyanine 540-mediated phototherapy by salicylate.
Anderson MS; Kalyanaraman B; Feix JB
Cancer Res; 1993 Feb; 53(4):806-9. PubMed ID: 8381329
[TBL] [Abstract][Full Text] [Related]
3. Role of cytoprotective mechanisms in the photochemical purging of autologous bone marrow grafts.
Yamazaki T; Sato Y; Sieber F
Exp Hematol; 1997 Jul; 25(7):629-37. PubMed ID: 9216739
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of merocyanine 540 uptake and photodynamic cell killing by salicylates.
Feix JB; Anderson MS; Kalyanaraman B
Cancer Res; 1994 Jul; 54(13):3474-8. PubMed ID: 8012969
[TBL] [Abstract][Full Text] [Related]
5. The alkyl-lysophospholipid, ET-18-OCH3 synergistically enhances the Merocyanine 540-mediated photoinactivation of leukemia cells: implications for the extracorporeal purging of autologous hematopoietic stem cells.
Yamazaki T; Sieber F
Bone Marrow Transplant; 1997 Jan; 19(2):113-9. PubMed ID: 9116607
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effects of merocyanine 540-mediated photodynamic therapy on cellular immune functions: A role in the prophylaxis of graft-versus-host disease?
Traul DL; Sieber F
J Photochem Photobiol B; 2015 Dec; 153():153-63. PubMed ID: 26410039
[TBL] [Abstract][Full Text] [Related]
7. Anti-tumor effect of Merocyanine 540-mediated photochemotherapy combined with Edelfosine: potential implications for the ex vivo purging of hematopoietic stem cell grafts from breast cancer patients.
Anderson GS; Miyagi K; Sampson RW; Sieber F
J Photochem Photobiol B; 2002 Nov; 68(2-3):101-8. PubMed ID: 12468204
[TBL] [Abstract][Full Text] [Related]
8. Effect of hypothermia on the merocyanine 540-mediated purging of hematopoietic cells.
Yamazaki T; Sieber F
J Hematother; 1997 Feb; 6(1):31-9. PubMed ID: 9112216
[TBL] [Abstract][Full Text] [Related]
9. Potentiation of the antitumor effect of Merocyanine 540-mediated photodynamic therapy by amifostine and amphotericin B.
Tsujino I; Miyagi K; Sampson RW; Sieber F
Photochem Photobiol; 2006; 82(2):458-65. PubMed ID: 16613499
[TBL] [Abstract][Full Text] [Related]
10. Selenoperoxidase-mediated cytoprotection against merocyanine 540-sensitized photoperoxidation and photokilling of leukemia cells.
Lin F; Geiger PG; Girotti AW
Cancer Res; 1992 Oct; 52(19):5282-90. PubMed ID: 1394132
[TBL] [Abstract][Full Text] [Related]
11. Merocyanine 540-sensitized photoinactivation of leukemia cells: effects of dose fractionation.
Qiu K; Sieber F
Photochem Photobiol; 1992 Oct; 56(4):489-93. PubMed ID: 1454878
[TBL] [Abstract][Full Text] [Related]
12. [Merocyanine 540-mediated photodynamic therapy inhibits P-glycoprotein (P-gp) activity in adriamycin-resistant K562 cells].
Sato Y; Yamazaki T; Yasukawa K; Kaneita Y; Mochimaru J; Hanai M; Irie T; Kura Y; Sawada U; Horie T
Gan To Kagaku Ryoho; 1999 Dec; 26(14):2195-200. PubMed ID: 10635304
[TBL] [Abstract][Full Text] [Related]
13. Dye-mediated photosensitization of murine neuroblastoma cells.
Sieber F; Sieber-Blum M
Cancer Res; 1986 Apr; 46(4 Pt 2):2072-6. PubMed ID: 3512078
[TBL] [Abstract][Full Text] [Related]
14. Investigation of the usefulness of the photodynamic reaction for the purging of bone marrow from metastatic neuroblastoma cells.
Köhler A; Müller A; Zintl F
J Photochem Photobiol B; 1993 Aug; 19(3):227-9. PubMed ID: 8229464
[TBL] [Abstract][Full Text] [Related]
15. Merocyanine 540-sensitized photoinactivation of high-grade non-Hodgkin's lymphoma cells: potential application in autologous BMT.
Itoh T; Messner HA; Jamal N; Tweeddale M; Sieber F
Bone Marrow Transplant; 1993 Sep; 12(3):191-6. PubMed ID: 8241975
[TBL] [Abstract][Full Text] [Related]
16. Postirradiation hyperthermia selectively potentiates the merocyanine 540-sensitized photoinactivation of small cell lung cancer cells.
Tsujino I; Anderson GS; Sieber F
Photochem Photobiol; 2001 Feb; 73(2):191-8. PubMed ID: 11272734
[TBL] [Abstract][Full Text] [Related]
17. Genetic variability in the response of normal murine hematopoietic progenitor cells to extracorporeal photochemotherapy.
Tsujino I; Sieber F
Photochem Photobiol; 2000 Dec; 72(6):810-4. PubMed ID: 11140270
[TBL] [Abstract][Full Text] [Related]
18. Selective killing of leukemic cells by merocyanine 540-mediated photosensitization.
Sieber F; Spivak JL; Sutcliffe AM
Proc Natl Acad Sci U S A; 1984 Dec; 81(23):7584-7. PubMed ID: 6594700
[TBL] [Abstract][Full Text] [Related]
19. Hyperresistance of leukemia cells to photodynamic inactivation after long-term exposure to hemin.
Lin F; Girotti AW
Cancer Res; 1996 Oct; 56(20):4636-43. PubMed ID: 8840977
[TBL] [Abstract][Full Text] [Related]
20. Preferential inactivation of paediatric solid tumour cells by sequential exposure to Merocyanine 540-mediated photodynamic therapy and Edelfosine: implications for the ex vivo purging of autologous haematopoietic stem cell grafts.
Anderson GS; Tsujino I; Miyagi K; Sampson R; Sieber F
J Photochem Photobiol B; 2003 Feb; 69(2):87-95. PubMed ID: 12633981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
